Geode Capital Management
SPHS

Geode Capital Management’s Sophiris Bio, Inc. SPHS Stock Holding History

Geode Capital Management’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-243,523
Closed -$90K – 4288
2019
Q4 		$90K Hold
243,523
– – ﹤0.01% 3985
2019
Q3 		$142K Hold
243,523
– – ﹤0.01% 3875
2019
Q2 		$205K Hold
243,523
– – ﹤0.01% 3786
2019
Q1 		$241K Hold
243,523
– – ﹤0.01% 3683
2018
Q4 		$202K Buy
243,523
+31,579
+15% +$62.1K ﹤0.01% 3679
2018
Q3 		$591K Hold
211,944
– – ﹤0.01% 3406
2018
Q2 		$595K Buy
211,944
+192,902
+1,013% +$573K ﹤0.01% 3378
2018
Q1 		$38K Hold
19,042
– – ﹤0.01% 3978
2017
Q4 		$43K Hold
19,042
– – ﹤0.01% 3943
2017
Q3 		$40K Hold
19,042
– – ﹤0.01% 3965
2017
Q2 		$41K Buy
19,042
+3,815
+25% +$9.34K ﹤0.01% 3987
2017
Q1 		$43K Buy
15,227
+4,028
+36% +$11K ﹤0.01% 3968
2016
Q4 		$31K Hold
11,199
– – ﹤0.01% 3974
2016
Q3 		$34K Buy
+11,199
New +$42.1K ﹤0.01% 3957

Other funds holding SPHS

HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
ACM
AUA Capital Management Camp Hill, Pennsylvania $216M AUM 19.17% 1-Year Est. Return

Geode Capital Management's SPHS Position: Q1 2020 in Review

Geode Capital Management sold out of Sophiris Bio, Inc. (SPHS) in Q1 2020, closing a stake of 243,523 shares — an estimated $90K sold.

Geode Capital Management first reported a position in SPHS in Q3 2016 and held it in 14 quarters. The position peaked at $595K in Q2 2018. 3 funds tracked by Wall St. Rank hold SPHS as of Q1 2020.

  • Geode Capital Management reported no remaining Sophiris Bio, Inc. position as of Q1 2020 after selling out during the quarter.
  • Geode Capital Management sold 243,523 Sophiris Bio, Inc. shares in Q1 2020, an estimated $90K.
  • Geode Capital Management first reported a position in Sophiris Bio, Inc. in Q3 2016 and held it in 14 quarters.
  • Geode Capital Management's Sophiris Bio, Inc. position peaked at $595K in Q2 2018.
  • 3 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q1 2020.

Based on Geode Capital Management's 13F filing for Q1 2020, filed 14 May 2020.